ArticleAnnals of dermatology2025

Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice.

Teppei Hagino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.